SEC reporting owner
| Reporting owner CIK | 0001938192 |
|---|---|
| Issuers | 2 |
| Qualifying disclosures | 7 |
| Public purchases | 0 |
| Recent-window purchases | 0 |
| Recent-window sales | 5 |
| Last public filing | 2026-01-13 |
| Coverage | verified |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-01-12 | 2026-01-12 | ZYME | S | 9,560 | Not reported |
| 2026-01-12 | 2026-01-12 | ZYME | A | 66,000 | Not reported |
| 2026-01-12 | 2026-01-12 | ZYME | A | 47,000 | Not reported |
| 2026-01-12 | 2026-01-12 | ZYME | A | 70,000 | Not reported |
| 2026-01-05 | 2026-01-05 | ZYME | S | 10,821 | Not reported |
| 2026-01-05 | 2026-01-05 | ZYME | S | 9,289 | Not reported |
| 2025-01-10 | 2025-01-10 | ZYME | A | 53,000 | Not reported |
| 2025-01-10 | 2025-01-10 | ZYME | A | 79,000 | Not reported |
| 2025-01-06 | 2025-01-06 | ZYME | S | 11,408 | Not reported |
| 2025-01-06 | 2025-01-06 | ZYME | S | 9,792 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.